Medicine & Life Sciences
Transplants
100%
Stem Cell Transplantation
90%
Allogeneic Cells
87%
Hematopoietic Stem Cell Transplantation
85%
Graft vs Host Disease
79%
Bone Marrow
76%
Cell Transplantation
76%
Transplantation
64%
Stem Cells
62%
Acute Myeloid Leukemia
57%
Tissue Donors
56%
T-Lymphocytes
51%
Survival
48%
Multiple Myeloma
46%
Homologous Transplantation
46%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
46%
Leukemia
45%
Fetal Blood
42%
Drug Therapy
40%
Unrelated Donors
40%
Blood Cells
39%
Bone Marrow Transplantation
39%
Chimeric Antigen Receptors
38%
Cyclophosphamide
38%
Busulfan
36%
Recurrence
36%
Neoplasms
35%
Therapeutics
35%
Hematopoietic Stem Cells
34%
fludarabine
32%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30%
Hematologic Neoplasms
27%
Myelodysplastic Syndromes
26%
Melphalan
26%
Cell- and Tissue-Based Therapy
25%
Autologous Transplantation
23%
Mortality
23%
Progression-Free Survival
21%
Granulocyte Colony-Stimulating Factor
21%
Breast Neoplasms
21%
Imatinib Mesylate
20%
Peripheral Blood Stem Cells
20%
Cytogenetics
19%
Lymphoma
19%
Natural Killer Cells
18%
Immunotherapy
18%
Transplant Recipients
16%
B-Cell Chronic Lymphocytic Leukemia
15%
Mesenchymal Stem Cells
15%
Hodgkin Disease
15%
Siblings
14%
Non-Hodgkin's Lymphoma
13%
Philadelphia Chromosome
13%
Stem Cell Factor
13%
Confidence Intervals
13%
Protein-Tyrosine Kinases
13%
Incidence
12%
Blood Component Removal
12%
Primary Myelofibrosis
12%
Allografts
12%
B-Lymphocytes
12%
Rituximab
12%
Lymphocytes
12%
HLA Antigens
11%
Antigens
11%
Clinical Trials
11%
Cytarabine
11%
Cytomegalovirus
11%
Aplastic Anaemia
11%
Whole-Body Irradiation
11%
Filgrastim
10%
Carmustine
10%
Safety
10%
Adoptive Immunotherapy
10%
Tacrolimus
10%
GATA2 Deficiency
10%
Hematopoiesis
10%
Myeloid Leukemia
10%
Myeloid Cells
10%
Residual Neoplasm
9%
In Vitro Techniques
9%
Disease-Free Survival
9%
Lymphoma, Large B-Cell, Diffuse
9%
Leukemia, Myeloid, Chronic Phase
9%
Cell Line
9%
Peripheral Blood Stem Cell Transplantation
9%
Dendritic Cells
9%
Hematopoietic Stem Cell Mobilization
9%
Blood Platelets
9%
Cytotoxic T-Lymphocytes
9%
Lenalidomide
8%
Etoposide
8%
Mantle-Cell Lymphoma
8%
Bone Marrow Cells
8%
Clofarabine
8%
Autografts
8%
Thiotepa
8%
Cytokines
8%
Haploidentical Transplantation
8%